Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

12.5%

2 terminated out of 16 trials

Success Rate

66.7%

-19.9% vs benchmark

Late-Stage Pipeline

13%

2 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed with results

Key Signals

2 with results67% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (10)
P 3 (2)

Trial Status

Completed4
Recruiting3
Active Not Recruiting3
Terminated2
Not Yet Recruiting2
Unknown1

Trial Success Rate

66.7%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT07743021Recruiting

Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data

NCT07465640Not ApplicableRecruiting

Evaluating the Efficacy of Pulsating Electromagnetic Field Therapy by CRAD ULCER X-01 for Diabetic Foot Ulcers

NCT07696728Not ApplicableRecruitingPrimary

Pulsed Electromagnetic Field Therapy for Diabetic Foot Ulcer Sensation

NCT07316699Enrolling By InvitationPrimary

Evaluation of the Psychometric Properties of the Turkish Version of the Hypoglycaemia Self-Care Behaviour Scale

NCT07432724Not ApplicableNot Yet RecruitingPrimary

This Study is Conducted to Evaluate the 18-month Clinical Performance of Complete Bioactive Restorative System for Occlusal Restorations Between Diabetic and Non-diabetic Patients.

NCT07316322Not Yet RecruitingPrimary

Central Sensitization in Painful and Painless Diabetic Peripheral Neuropathy

NCT07272993Not ApplicableActive Not Recruiting

Effect of Golden Rice-Piper Crocatum Cookies on Neuropathy Prevention in Diabetes

NCT07268781Not ApplicableActive Not RecruitingPrimary

Impact of Golden Rice-Piper Crocatum Cookies on Lipid Control in Diabetes Mellitus Patients

NCT06973954Not ApplicableActive Not RecruitingPrimary

Improving the Activation Level of Diabetic Individuals

NCT02616263Not ApplicableCompletedPrimary

Metatarsal Phalangeal Joint Deformity Progression - R01

NCT03174522Phase 3Terminated

The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM

NCT05478070Not ApplicableUnknownPrimary

Continuous Glucose Monitoring for Personal Protective Equipment Evaluation

NCT02685384CompletedPrimary

Post ACA Reform: Evaluation of Community Health Center Care of Diabetes

NCT03111238Phase 3Terminated

The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM

NCT02034045Not ApplicableCompletedPrimary

Expanding Paramedicine in the Community

NCT01855243Not ApplicableCompletedPrimary

Comparison on Efficacy and Safety of Three Inpatient Insulin Therapy in Type2 DM

Showing all 16 trials

Research Network

Activity Timeline